TABLE 1.

Lytic spectra and efficiency of plating of the Providencia rettgeri phage PR1

Species	Strain	Sourcea	Patient gender	Antibiotic resistance profileb	PR1 infectivity	PR1 EOPc
P. rettgeri	PR 1	Expectoration	Male	AM, AMC CXM, FM	+	High
	PR 2	Urine	Male	AM, AMC CXM, FM, GM, NN, SXT	−
	PR 3	Urine	Male	AM, AMC CXM, FM, GM, NN	+	High
	PR 4	Urine	Male	AM, AMC CXM, FM, GM, NN	+	High
	PR 5	Urine	Male	AM, AMC CXM, FM	+	LFW
	PR 6	Urine	Female	AM, AMC CXM, FM, GM, NN	+	LFW
	PR 7	Pus	Male	AM, AMC CXM, FM, GM, NN	−
	PR 8	Urine	Male	AM, AMC CXM, FM, GM, NN	−
	PR 9	Urine	Male	AM, AMC CXM, FM	+	High
	PR 10	Expectoration	Male	AM, AMC CXM, FM, GM, NN, SXT	+	High
	PR 11	Urine	Male	AM, AMC CXM, FM, GM, NN	+	High
	PR 12	Urine	Male	AM, AMC CXM, FM, GM, NN	+	Low
P. stuartii	PS 1	Urine	Male	AM, AMC CXM, FM, GM, NN, LVX	−
	PS 2	Bronchus aspirate	Male	AM, AMC CXM, FM, GM, NN, LVX, CIP, SXT	−
	PS 3	Expectoration	Male	AM, AMC CXM, FM, GM, NN, LVX, CIP	−
	PS 4	Cutaneous exudate	Female	AM, AMC CXM, FM, GM, NN, LVX, CIP	−
	PS 5	Urine	Male	AM, AMC CXM, FM, GM, NN, LVX, SXT	−
	PS 6	Urine	Unknown	AM, AMC CXM, FM, GM, NN, LVX, CIP	−
	PS 7	Urine	Male	AM, AMC CXM, FM, GM, NN, LVX, CIP	−
	PS 8	Urine	Male	AM, AMC CXM, FM, GM, NN, LVX, CIP	−
	PS 9	Unknown	Unknown	AM, AMC CXM, FM, GM, NN, LVX, CIP	−
	PS 10	Urine	Female	AM, AMC CXM, FM, GM, NN, LVX, CIP	−
	PS 11	Urine	Male	AM, AMC CXM, FM, GM, NN	−
	PS 12	Expectoration	Male	AM, AMC CXM, FM, GM, NN, LVX, CIP, SXT	−
	PS 13	Cutaneous exudate	Male	AM, AMC CXM, FM, GM, NN, LVX, CIP	−
	PS 14	Urine	Male	AM, AMC CXM, FM, GM, NN	−
	PS 15	Bronchial aspirate	Male	AM, AMC CXM, FM, GM, NN	−
P. alcalifaciens	PA 1	Urine	Male	AM, AMC CXM, FM, GM, NN	−
C. freundii	CF 1	Salmonella Genetic Stock Centre (EC592)			−
M. morganii	MM	Salmonella Genetic Stock Centre (CDC 4195-69)			−
P. mirabilis	PM	ATCC (CECT 4101)			−
P. vulgaris	PV	ATCC (CECT 174)			−
E. coli	EC	ATCC (CECT 432)			−

^aATCC, American Type Culture Collection.

^bAM, ampicillin; AMC, amoxicillin-clavulanic acid; CXM, cefuroxime; FM, framycetin; GM, gentamicin; NN, tobramycin; LVX, levofloxacin; CIP, ciprofloxacin; SXT, co-trimoxazole.

^cThe EOP was recorded as high or low, representing EOPs higher or lower than 1%, respectively. LFW, lysis-from-without events.